successful investors ain’t made in bull markets I can assure you. With the recent sell down in biotech companies globally, the ones that will thrive are the ones with a compelling and safe innovation to tackle various health issues. I’m glad that we are going up the acceptance and drug tolerance stage and we need to clear each hurdle fast. After which would be real life applications and then this shd be be a $500M market cap company at the very least.
https://www.mckinsey.com/industries/life-sciences/our-insights/what-are-the-biotech-investment-themes-that-will-shape-the-industry
successful investors ain’t made in bull markets I can assure...
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $130.5M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 64.0¢ | $31.74K | 49.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24674 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
65.0¢ |
Change
0.000 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| 64.5¢ | 65.0¢ | 64.0¢ | 5994 | ||
| Last updated 11.57am 03/05/2024 ? | |||||
| RCE (ASX) Chart |